Share chart NetraMark Holdings Inc.
Extended chart
Simple chart
About
NetraMark Holdings Inc. develops artificial intelligence and machine learning solutions for the pharmaceutical industry in Canada. Its products suite comprises NetraAI, an interactive augmented intelligence platform; Netra Shatter; and Netra Health Atlas. The company was formerly known as Nurosene Health Inc. and changed its name to NetraMark Holdings Inc. in February 2023. NetraMark Holdings Inc. was founded in 2016 and is headquartered in Toronto, Canada.
| Industry |
Health Care Technology |
| Sector |
Health Care |
| Валюта |
usd |
| Валюта отчета |
cad |
| Сайт |
https://www.netramark.com
|
| Цена ао |
0.1814 |
| Change price per day: |
0% (0.716) |
| Change price per week: |
+18.35% (0.605) |
| Change price per month: |
+42.71% (0.5017) |
| Change price per 3 month: |
+294.71% (0.1814) |
| Change price per half year: |
+232.87% (0.2151) |
| Change price per year: |
+186.74% (0.2497) |
| Change price per 3 year: |
0% (0.716) |
| Change price per 5 year: |
0% (0.716) |
| Change price per 10 year: |
0% (0.716) |
| Change price per year to date: |
0% (0.716) |
|
|
Underestimation
| Title |
Value |
Grade |
| P/S |
0 |
0 |
| P/BV |
0 |
0 |
| P/E |
0 |
0 |
| EV/EBITDA |
0 |
0 |
| Total: |
|
2.5 |
|
Efficiency
| Title |
Value |
Grade |
| ROA, % |
0 |
0 |
| ROE, % |
0 |
0 |
| Total: |
|
0 |
|
|
|
Dividends
| Title |
Value |
Grade |
| Div yield, % |
0 |
0 |
| DSI |
0 |
0 |
| Total: |
|
0 |
|
Debt
| Title |
Value |
Grade |
| Debt/EBITDA |
0 |
10 |
| Total: |
|
10 |
|
Growth impulse
| Title |
Value |
Grade |
| Yield Revenue, % |
-21.02 |
0 |
| Yield Ebitda, % |
0 |
0 |
| Yield EPS, % |
187.28 |
10 |
| Total: |
|
6 |
|
| Head |
Job title |
Payment |
Year of birth |
| Mr. George Achilleos |
CEO & Director |
|
|
| Mr. Josh Spiegel |
President |
|
|
| Mr. Daniel Gallucci |
Founder, Chief Performance Officer & Director |
|
1977 (48 years) |
| Dr. Joseph Geraci Ph.D. |
Founder, Chief Scientific & Technical Officer and Director |
|
|
| Mr. Swapan Kakumanu ACA, ACWA, CGA |
Chief Financial Officer |
|
1969 (56 years) |
| Ms. Jaime Hackett |
Vice President of Marketing |
|
|
| Dr. Luca Pani M.D. |
Chief Innovation & Regulatory Officer and Chief Medical Advisor |
|
|
| Dr. Kaveh Kavoosi |
Head of Progressive Medicine |
|
|
| Dr. Larry Alphs |
Chief Medical Officer & Member of Advisory Board |
|
|
| Mr. Mark Smithyes |
President of NetraMark |
|
1970 (55 years) |
